NEW ORLEANS, Oct. 20, 2017 -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 27, 2017 to file lead plaintiff applications in a securities class action lawsuit against Vitamin Shoppe, Inc. (NYSE:VSI), if they purchased the Company’s shares between the expanded period of March 1, 2017 and August 8, 2017, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of New Jersey.
Get Help
Vitamin Shoppe investors should visit us at https://www.claimsfiler.com/cases/nasdaq-vsi or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
Vitamin Shoppe and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On March 1, 2017, Vitamin Shoppe announced that it expected to deliver “[f]ully diluted earnings per share in the range of $1.95 - $2.20” during fiscal year 2017. Subsequently, on May 10, 2017, the Company slashed FY17 guidance by more than 45% and then on August 9, 2017, revealed it was taking a goodwill impairment charge of $168 million and as a result, a GAAP loss per share of $6.73 in 2Q17.
On this news, the price of Vitamin Shoppe’s shares plummeted.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.


NextEra Energy Stock Rises After Reaffirming Earnings and Dividend Growth Outlook
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Trump Blocks HieFo’s Emcore Chip Assets Deal Over National Security Concerns
Short Interest Rises in Trump Media Stock After $6 Billion Merger Announcement
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Air China Orders 60 Airbus A320neo Jets in $9.5 Billion Deal as Airbus Strengthens Grip on China Market
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro 



